Pre-market Hot Trades in US Stocks
Top Gainers in Pre-market US Stocks
PepGen is up 81.58% in pre-market trading. Based on recent key news:
<ol>
<li>
On September 25, PepGen announced a public offering of $100 million at a price of $3.20 per share, driving the stock price up. This move aims to provide funding for research and clinical trials. Source: Company announcement
</li>
<li>
On September 24, PepGen released positive clinical data from its FREEDOM-DM1 study, showing a splice correction rate of 53.7% for the 15 mg/kg dose of PGN-EDODM1, resulting in a significant stock price increase. Source: Company announcement
</li>
<li>
On September 25, Guggenheim reiterated its buy rating on PepGen and maintained a target price of $6, further boosting market confidence. Source: Analyst report The biotechnology sector has been active recently, with significant capital inflows
</li>
</ol>

NBTX

SHFS

Nanobiotix SA pre-market down 9.79%; SHF pre-market down 9.63%; PepGen pre-market up 81.58%; WORK Medical Tech pre-market up 60.89%; OFA pre-market up 40.60%

Pre-market hot trades in US stocks: Nanobiotix SA pre-market down 9.79%; SHF pre-market down 9.63%